ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,042Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 384

$637K Total Retail Price of All Prescriptions

Rank: 32 out of 384

617 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 617 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 12,382 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 882 742 1 1
METFORMIN HCL 658 466 2 2
LEVOTHYROXINE SODIUM 576 473 3 11
GABAPENTIN 568 438 4 4
RANITIDINE HCL 486 387 5 7
AMLODIPINE BESYLATE 479 411 6 3
GLIPIZIDE 465 377 7 27
OMEPRAZOLE 439 334 8 8
LISINOPRIL 408 293 9 14
LOSARTAN POTASSIUM 384 290 10 5
SYNTHROID 328 222 11 9
ENALAPRIL MALEATE 323 278 12 6
ALENDRONATE SODIUM 297 283 13 20
LOSARTAN-HYDROCHLOROTHIAZIDE 293 234 14 10
METOPROLOL TARTRATE 274 193 15 15
ATENOLOL 210 173 16 12
FUROSEMIDE 206 170 17 17
GLIMEPIRIDE 201 134 18 18
HYDROCHLOROTHIAZIDE 195 155 19 16
HUMULIN 70-30 194 136 20 47
TRAMADOL HCL-ACETAMINOPHEN 189 154 21 13
ZOLPIDEM TARTRATE 175 156 22 19
ISOSORBIDE MONONITRATE ER 145 142 23 28
CLOPIDOGREL 131 104 24 30
VERAPAMIL ER 128 100 25 41
PANTOPRAZOLE SODIUM 127 104 26 39
DONEPEZIL HCL 122 115 27 33
AMLODIPINE BESYLATE-BENAZEPRIL 111 101 28 43
TRAMADOL HCL 111 76 28 40
DICLOFENAC POTASSIUM 108 77 30 38
WARFARIN SODIUM 107 81 31 48
MECLIZINE HCL 106 89 32 73
METOPROLOL SUCCINATE 104 98 33 21
PLAVIX 103 91 34 32
NABUMETONE 102 68 35 34
ADVAIR DISKUS 101 52 36 65
HUMULIN N 101 91 36 57
DIOVAN 98 65 38 54
CITALOPRAM HBR 96 86 39 68
INSULIN SYRINGE 94 51 40 46
GLYBURIDE MICRONIZED 93 78 R 41 106
GEMFIBROZIL 87 49 42 74
PROAIR HFA 87 48 42 112
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 54 44 78
AZITHROMYCIN 85 57 44 59
PAROXETINE HCL 83 53 46 37
PREDNISOLONE 82 55 47 166
EVISTA 81 71 48 52
CARVEDILOL 80 73 49 23
SINGULAIR 78 51 50 63
DOXAZOSIN MESYLATE 77 45 51 29
NAPROXEN 73 57 52 129
ZETIA 73 65 52 69
NAMENDA 73 69 52 67
CIPROFLOXACIN HCL 73 57 52 50
FENOFIBRATE 72 54 56 53
JANUVIA 71 50 57 108
LYRICA 70 70 58 92
CLONIDINE HCL 69 41 59 84
CAPTOPRIL 67 46 60 72
DIGOXIN 63 58 61 49
SERTRALINE HCL 63 59 61 26
IRBESARTAN 60 46 63 55
CALTRATE 600 + D 55 49 64 196
OXYCODONE-ACETAMINOPHEN 54 17 S2 65 93
BETAMETHASONE DIPROPIONATE 53 41 66 175
PRAVASTATIN SODIUM 53 53 66 24
ASPIRIN EC 52 45 68 31
FINASTERIDE 51 51 69 62
LANTUS 50 25 70 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.